Chiasma Inc.

About Chiasma Inc.

Chiasma is a biopharmaceutical company focused on improving the lives of patients who face challenges associated with existing treatments for their rare and serious chronic diseases. Employing its Transient Permeability Enhancer (TPE®) technology platform, Chiasma seeks to select, develop and ultimately commercialize oral medications that are currently only available as injections.
YEAR FOUNDED:
2001
LEADERSHIP:
Founders: Guy Yachin, Muli Ben Sasson
CEO: Mark Leuctenberger
CFO: Mark Fitzpatrick
JOBS:
Please click here for Chiasma job opportunitites.
CLINICAL TRIAL:
Please click here for clinical trial information.